FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Biomm's Trailing 12-Month Free Cash Flow is R$-108.5 Mil, and Market Cap is R$848.5 Mil. Therefore, Biomm's FCF Yield % for today is -12.79%.
The historical rank and industry rank for Biomm's FCF Yield % or its related term are showing as below:
BSP:BIOM3'
s FCF Yield % Range Over the Past 10 Years
Min: -29.37 Med: -12.93 Max: -4.39
Current: -12.79
During the past 13 years, the highest FCF Yield % of Biomm was -4.39%. The lowest was -29.37%. And the median was -12.93%.
BSP:BIOM3's FCF Yield % is ranked worse than 57.63% of 1409
companies
in the Biotechnology industry
Industry Median: -9.33
vs BSP:BIOM3: -12.79
Biomm's FCF Margin % for the quarter that ended in Mar. 2026 was -0.73%.
Biomm FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Biomm FCF Yield % Related Terms
Biomm FCF Yield % Historical Data
* Premium members only.
The historical data trend for Biomm's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:BIOM3 vs VRTX, REGN, ALNY: FCF Yield % Comparison
For the Biotechnology subindustry, Biomm's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biomm FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Biomm's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Biomm's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biomm (BSP:BIOM3) has a FCF Yield % of -12.79 as of Jul. 13, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Biomm and its competitors. According to the industry distribution chart, Biomm ranks #812 out of 1409 companies in the Biotechnology industry, placing it in the top 57.6%.
Is Biomm's FCF Yield % too high?
Biomm's current FCF Yield % is -12.79. Based on the distribution chart, Biomm ranks #812 out of 1409 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Biomm has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biomm's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Biomm ranks #812 out of 1409 companies for FCF Yield %. This places Biomm in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Biomm and its competitors. Biomm's current FCF Yield % is -12.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomm stock overvalued right now?
Based on GuruFocus' analysis, Biomm (BSP:BIOM3) is currently considered Possible Value Trap. The stock's GF Value™ is R$15.96, compared to a current price of R$6.20 — trading 61.2% below its estimated fair value. The current FCF Yield % is -12.79. Biomm's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Biomm (BSP:BIOM3), the current FCF Yield % is -12.79 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biomm (BSP:BIOM3) Overvalued in 2026?
Based on GuruFocus' analysis, Biomm stock appears to be undervalued.
The current stock price of R$6.20 is trading 61.2% below its estimated GF Value™ of R$15.96.
GuruFocus considers Biomm to be Possible Value Trap.
Key valuation signals for BSP:BIOM3:
FCF Yield %: -12.79
GF Value™: R$15.96 vs. price of R$6.20 (61.2% below fair value)
No single metric tells the full story. See the BSP:BIOM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biomm SA is engaged in biotechnological processes for the production of active pharmaceutical ingredients and other industrial purposes, such as enzymes used in the production of Biofuels.The Company is patented for insulin production.The company develops processes for the production of insulin and other biotech products, as well as processes for other industrial applications, such as enzymes that are used in the production of biofuels.
51GF Score
Get the complete analysis for BSP:BIOM3
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:BIOM3 has been successfully added to your 
